Global Vascular Grafts Market to Grow at a CAGR of 6.86% Through 2032, Driven by Cardiovascular Burden and Surgical Advancements | DelveInsight

The vascular grafts market is witnessing steady growth, propelled by the rising incidence of cardiovascular diseases, aneurysms, and peripheral artery disease (PAD) across aging populations worldwide. As surgical interventions for these conditions become more advanced, the need for durable and biocompatible graft solutions is surging.

Vascular grafts are critical for bypass surgeries, hemodialysis access, and aortic aneurysm repair, particularly in patients where native vessels are unsuitable. The market includes synthetic grafts (e.g., ePTFE, Dacron), biological grafts, and biosynthetic hybrids tailored for both large and small-diameter applications. Innovations in graft coatings, drug-eluting materials, and infection-resistant designs are improving patency rates and post-surgical outcomes.

DelveInsight's Vascular Grafts Market Insights, Competitive Landscape, and Market Forecast - 2032 offers a comprehensive analysis of the market dynamics across the US, EU4 (Germany, France, Italy, Spain), the UK, Japan, and other key geographies. The report segments the market by product type, indication, material, and end-user, while also examining reimbursement challenges, regulatory pathways, and pricing variability.

Leading players such as BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., are expanding their portfolios through strategic collaborations and innovation in graft design, aiming to improve long-term vascular access and surgical success.

As endovascular techniques grow in adoption alongside open surgical procedures, the vascular grafts market is positioned to advance through technological refinement, enhanced biocompatibility, and expanding treatment access-ushering in a new era of precision vascular surgery.

Explore the latest trends and growth drivers in the Vascular Grafts market-download your sample report now https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Vascular Grafts Market Report
• The global vascular grafts market was valued at USD 1.86 billion in 2024 and is projected to reach USD 3.15 billion by 2032, growing at a CAGR of 6.86%.
• As per DelveInsight estimates, North America is anticipated to dominate the global vascular grafts market during the forecast period.
• Notable vascular grafts companies such as BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH, and several others are currently operating in the Vascular Grafts market.
• In December 2024, the FDA approved Symvess, the first acellular tissue-engineered vessel for adults needing urgent revascularization in extremity arterial injuries when vein grafts aren't an option.
• In November 2024, Healionics received FDA Breakthrough Device designation for its StargraftTM arteriovenous graft, intended to improve outcomes in dialysis access by reducing infection and thrombosis risks
• In January 2024, W. L. Gore & Associates announced FDA approval for the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE), the first off-the-shelf endovascular graft for the treatment of complex aneurysmal disease involving the visceral aorta.

To read more about the latest highlights related to the vascular grafts market, get a snapshot of the key highlights entailed in the global vascular grafts market report here https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Vascular Grafts Overview
Vascular grafts are specialized medical devices used to replace, bypass, or repair damaged or diseased blood vessels. They are essential in surgical procedures for restoring normal blood flow in conditions like atherosclerosis, aneurysms, and peripheral artery disease. Typically made from synthetic materials such as expanded polytetrafluoroethylene (ePTFE) or Dacron, or derived from biological sources, these grafts are used when native vessels are unsuitable for repair.

Applications of vascular grafts span coronary artery bypass grafting (CABG), hemodialysis access in patients with renal failure, and complex aortic or peripheral vascular reconstructions. Recent advancements have led to the development of drug-eluting and infection-resistant grafts, improving durability and post-operative outcomes. As cardiovascular disease remains a leading global health concern, the demand for vascular grafts continues to grow, supported by surgical innovation and improved biomaterials.

Vascular Grafts Market Insights
North America is projected to lead the vascular grafts market in 2024, driven by a high prevalence of vascular diseases, advanced healthcare infrastructure, and strong adoption of endovascular procedures. The presence of key medical device companies, rising healthcare spending, and favorable reimbursement policies also contribute to market growth. Increasing awareness of early cardiovascular diagnosis and treatment, particularly for conditions like abdominal aortic aneurysms, is further fueling demand.

According to the CDC (2024), about 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022, while 12.1 million Americans were projected to have atrial fibrillation by 2023. Additionally, over 795,000 people suffer strokes annually in the U.S., with nearly one in four being recurrent cases-many of which require graft-based interventions.

National campaigns such as American Heart Month (Feb 2024) have promoted early diagnosis and preventive care, further supporting vascular graft use. Meanwhile, product innovation continues to drive the market. For example, in May 2023, Terumo Aortic received FDA approval to expand indications for its Relay®Pro Stent-Graft system for TEVAR in patients with smaller vessels. These factors collectively reinforce North America's dominance in the vascular grafts market.

To know more about why North America is leading the market growth in the vascular grafts market, get a snapshot of the vascular grafts market outlook here https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Vascular Grafts Market Dynamics
According to the British Heart Foundation (2025), around 640 million people globally live with heart and circulatory diseases, with coronary heart disease affecting 200 million individuals-110 million men and 80 million women. Additionally, an estimated 101 million people are stroke survivors, and at least 13 million live with congenital heart disease. These conditions often lead to blocked or damaged vessels, increasing the demand for vascular grafts to restore circulation.

Growing awareness campaigns like World Heart Day promote early diagnosis and preventive care, further driving the use of vascular grafts in surgical interventions. Rising product development is also fueling market growth. For instance, in September 2023, MicroPort® EndovastecTM received Thailand FDA approval for innovative grafts, including the CastorTM Branched Aortic Stent-Graft and HerculesTM LP for thoracic aneurysms.

Despite growth drivers, the market faces challenges from graft-related complications and rising product recalls, which may slightly restrain adoption.

Get a sneak peek at the vascular grafts market dynamics @ https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Vascular Grafts Market CAGR: ~13.21%
Key Vascular Grafts Companies: BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH, and others.

Vascular Grafts Market Segmentation
Market Segmentation By Product Type: Endovascular Grafts [Abdominal Grafts and Thoracic Grafts], Access Grafts, Peripheral Grafts, and Others), Type (Knitted, Woven, and others.
Market Segmentation By Material: Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and others.
Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the vascular grafts market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Vascular Grafts Market Report Introduction
2. Vascular Grafts Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Vascular Grafts Market Key Factors Analysis
6. Vascular Grafts Market Porter's Five Forces Analysis
7. Vascular Grafts Market Layout
8. Vascular Grafts Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.